OpGen (NASDAQ:OPGN) Now Covered by StockNews.com

Posted by on Apr 29th, 2025

StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Saturday morning. The brokerage issued a sell rating on the medical research company’s stock.

OpGen Price Performance

Shares of OpGen stock opened at $4.91 on Friday. OpGen has a 52 week low of $0.53 and a 52 week high of $5.39. The stock has a 50 day moving average price of $2.81 and a two-hundred day moving average price of $1.83.

OpGen Company Profile

(Get Free Report)

OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.

Further Reading

Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.